AppLovin Posts Q3 Beat, Hybrid Model Rollout Lifts Sentiment: Analysts
AppLovin shares surged after strong Q3 results; analysts raised targets, citing hybrid AI model rollout, 50%+ growth and upside potential.
Stocks · News reference
Nasdaq Tumbles 4.5%; Cardinal Health Shares Gain After Upbeat Q1 Earnings
U.S. stocks tumbled: Nasdaq -4.5%, S&P 500 -3.3%, Dow -2.5%. Cardinal Health rose on strong results; AppLovin surged 32%, while Veracyte fell 55%.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Macquarie Maintains Outperform on AppLovin, Raises Price Target to $470
Dow Jumps 1,569 Points, Chipmakers' Growth Beyond Phones, Arm's Server Share Grows
The Dow jumped 1,569 points on Wednesday as the midterm result reset expectations for Washington. Oil fell more than 8%, giving consumer businesses a different backdrop while punishing energy shares. Democrats won
Goldman Sachs Maintains Neutral on AppLovin, Raises Price Target to $445
Cardinal Health Sees Healthy Demand, Despite Modest Commodity Pressure
Cardinal Health tops Q1 2027 estimates, and raises guidance, as robust pharma sales offset petroleum headwinds in medical distribution.
Why Is Veracyte Stock Sinking Thursday?
Veracyte (VCYT) stock tumbled 54% to a new 52-week low as weaker-than-expected Decipher Prostate test volumes overshadowed Q3 earnings beat.